Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good article.
You did a great job with that!
Wrong. Real professionals have attention spans that are longer than a fruit fly.
I worry about these mRNA vaccines causing autoimmune diseases.
I wanted to share this found on YMB by FredSavage911?.
After the AMA Covid therapeutic lecture on Wednesday failed to discuss Leronlimab I called the FDA and sent Dr. Bailey the conference moderator an email to express my disappointment. Dr. Bailey emailed me back stating she did get several questions about LL and promised to address it during the next webinar. I received a call back yesterday from a man named Steve at the FDA who said he was a clinical pharmacist. He stated he and 20 other people are in charge of receiving calls about medications for covid. They keep tally of how many calls they get about each medication and those tallies get pushed up the line to higher ups. After a 10 minute conversation he consented that it is not necessarily the most logical and reasonable medications that get approved but ones that have the loudest voices behind them. I said that was ridiculous but he said unfortunately that’s America. Truly disheartening but I feel he is unfortunately right. So with that said call the fda and politely recommend they look at leronlimab very closely. Increase the tallies and make the voice for Leronlimab the loudest in the room. FDA 1-888-463-6332
Typically takes FDA 4 weeks to reply to EUA filings.
Charges couldn’t be proven and were withdrawn too.
Not impressed with Amarex, I think they are the root of many of the problems.
Looks to me like there are no intentions of ending OLE and EIND on CD12, and EUA is coming for COVID. Lack of information on CD16 supports that thesis, at least so far. IMHO, requiring further blinded trials withholding LL from placebo patients would be unethical given what is known from all actions and results with LL so far.
Great post. I agree with that.
Yep
Totally agree, it is a wasteful, emotional, and unrealistic discussion. Sort of like the people that think that a global carbon tax will stop climate change which has been going on since before there were humans.
Very happy to hear your good news. We have a winner in Leronlimab!
CC pr clearly says they filed.
BWA, you’re the man!
Thank you for doing that!
Great post!
Well, our share price is tanking today. Wonder why?
Someone else is probably doing it then.
Is it OK for Cytodyn’s COO to be running a log-hauler trial for CYDY as an investigator?
Uk?
We also know he received and was saved by LL as an early Covid patient. I imagine he is pretty passionate about it.
That gap can close as fast as it opened with just a lil earlier.
They might have been covered by Officers and Directors insurance and the insurance company decided it was expedient to settle.
MHRA is more professional and responsive to the needs of their country than FDA. Such an outcome makes sense. They have serious problems in the U.K. and MHRA are a serious no BS outfit.
Chewing through the ask pretty consistently today. MACD turning up to indicate downtrend reversal. Get it while you can. Make some money.
“failure to state a case”
There are many irons in the fire with Covid, and with other indications, inevitably the treatment is effective. The tides always go out more than usual in advance of a tidal wave.
Absolutely true
Thinking about his statement, it does not serve his interest if true and lists a very shallow reason for selling. Perhaps he is buying.
Good Luck to you. I think you may struggle to get back in.
Sounds like a possible thrombocytopenia reaction. They should do an autopsy.
Is CD16 recruiting? How can that be?
So what qualifies you to say that?
I’ve never seen any communication that they do require it nor any communication about our RO tests that we ran since the 2000’s. They DO require a Tropism assay to prove that the patient has an isolate that uses CCR5. These tests are highly variable and cost several thousand $ https://t.co/niJLX8V2Kq
— Bruce K. Patterson MD (@brucep13) March 11, 2021
As long as they control the narrative and the optics politically. What is Cytodyn filed a mITT analysis (already done by shareholder Dr John Breem), and simultaneously a phase 4 with no placebo. And then work the news and Congress and whatever venu to stimulate a conversation about ethics? Would that put them in a hot seat under a spotlight.
I think it is unethical to do otherwise.
It means nothing. That happens a lot on Friday.